Rethinking diagnostics in the fight against antimicrobial resistance
Alejandra Sanchez and Ben Wicks explore why primary care needs timely, pragmatic insight, not lab-grade certainty, to enable better antibiotic decisions and stewardship.
The coolest tech at CES 2026
CNET reporters have been inside CES 2026 all week, getting a glimpse into the future with the most interesting, innovative and cutting-edge tech available.
Getting ahead of the curve with Cambridge Consultants
The Eastern Promise podcast caught up with Cambridge Consultants Frances Metcalfe and Richard Traherne. Heads spun, as host Mike Rigby dug deep into the work of Capgemini’s deep tech powerhouse. Listen NOW!
Rebuilding the bio-economy: Japan’s green future
A thriving bio-economy depends on aligning public and private finance, it requires flexible, long-term funding and policy frameworks that reflect its unpredictable pace. The industry also needs to bridge the gap between academic knowledge and industrial needs.
Unlocking the potential of IP-free gene editing to gain commercial advantage
CC’s transdisciplinary development team has created a way to democratise gene editing. This IP-free gene editing method avoids the timescales and costs involved with commercially licensing current CRISPR/Cas9 editing techniques.